Table 3. Clinical and epidemiological characteristics of virus positive and negative groups.
| Virus Positive (n = 25) | Virus Negative (n = 45) | p value | |
|---|---|---|---|
| Median age in years (range +- SD) | 3.9 (0.3–17,9; +- 4.9) | 5,5 (0.3–17; +- 4.6) | 0.3a |
| Median Days of symptoms (range+- SD) | 6 (1–21; +-5.3) | 6 (0–30; +-5.5) | 0.7 a |
| Clinical Features | |||
| Change in Sinus Discharge | 21 (84%) | 26 (57.8%) | 0.03 |
| Worsening cough | 25 (100%) | 44 (97.8%) | 1 |
| Change in sputum pattern | 22 (88%) | 38 (84.4%) | 1 |
| Worsening dyspnea | 14 (56%) | 27 (60%) | 0.8 |
| Hemoptysis | 1 (4%) | 1 (2.2%) | 1 |
| Fatigue | 9 (36%) | 10 (22.2%) | 0.21 |
| Fever | 16 (64%) | 19 (42.2%) | 0.08 |
| Anorexia/weight loss | 14 (56%) | 26 (57.8%) | 0.89 |
| Sinus pain | 1 (4%) | 2 (4.4%) | 1 |
| Low oxygen saturation | 7 (28%) | 15 (33.3%) | 0.65 |
| Abnormal Chest Auscultation | 20 (80%) | 42 (93.3%) | 0.1 |
| Treatment | |||
| Antibiotics | 19 (76%) | 40 (88.9%) | 0.18 |
| Oseltamivir | 1 (4%) | 0 | 0.35 |
| Oxygen therapy | 6 (24%) | 15 (33.3%) | 0.41 |
| Noninvasive Ventilation | 3 (12%) | 4 (8.9%) | 0.69 |
| Hospital Admission | 10 (40%) | 21 (46.7%) | 0.11 |
| Mean length of hospital stay in days (range +- SD) | 14.6 (7–21; +- 3.8) | 16,5 (8–34; +- 5.6) | 0.45 a |
| Severity Scores | |||
| Mean CFCSc (range +- SD) | 30.3 (19–39; +- 5.4) | 29.4 (18–41; +- 5.9) | 0.25b |
| Mean Shwachman-Kulczycki Score (range +- SD) | 72.2 (45–95; +-11.9) | 71.6 (35–90; +-12.4) | 0.42 b |
aStudent’s T test.
bMann Whitney’s U test.
cCystic Fibrosis Clinical Score.